Valuation: Ibnsina Pharma

Market Cap 11.56B 226M 198M 183M 169M 318M 21.83B 323M 2.19B 860M 10.68B 850M 831M 36.8B P/E 2026 *
9.42x
P/E 2027 * 6.44x
Enterprise Value 17.38B 340M 298M 276M 254M 478M 32.81B 486M 3.3B 1.29B 16.05B 1.28B 1.25B 55.31B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.17x
Free-Float
70.08%
Yield 2026 *
2.62%
Yield 2027 * 5.06%
1 day-0.09%
Current month-1.71%
1 month-5.91%
3 months+2.78%
6 months+4.46%
Current year-2.13%
1 week 11.2
Extreme 11.2
11.65
1 month 11.2
Extreme 11.2
12.71
Current year 9.63
Extreme 9.63
13.72
1 year 9.63
Extreme 9.63
13.72
3 years 1.78
Extreme 1.78
13.72
5 years 1.1
Extreme 1.101
13.72
10 years 1.1
Extreme 1.101
13.72
Manager TitleAgeSince
Chief Executive Officer - 2000-12-17
Chief Executive Officer - 2000-12-17
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - 2000-12-17
Director/Board Member - 2000-12-17
Change 5-day change 1-year change 3-year change Capi.($)
-0.09%0.00%+14.70%+398.70% 229M
-1.62%+1.89%-22.03%-27.92% 15.14B
-1.74%+2.73%-27.87%-32.87% 6.93B
-0.91%+2.30%-21.44%-6.75% 6.13B
+3.36%+4.01%-9.08%-28.65% 3.73B
-0.46%+4.11%-38.48%-12.05% 3.25B
-0.39%-2.28%-29.80%-49.55% 3.13B
+1.35%+4.09%+10.77%-29.72% 3.12B
-1.83%-1.27%+96.15% - 2.57B
+0.64%+3.55%-17.85%-0.86% 2.53B
Average -0.17%+0.34%-4.49%+23.37% 4.68B
Weighted average by Cap. -0.67%+0.16%-14.37%-22.55%

Financials

2026 *2027 *
Net sales 89.87B 1.76B 1.54B 1.43B 1.31B 2.47B 170B 2.51B 17.05B 6.68B 83.02B 6.61B 6.46B 286B 101B 1.98B 1.74B 1.61B 1.48B 2.79B 191B 2.83B 19.19B 7.52B 93.47B 7.44B 7.28B 322B
Net income 1.33B 25.97M 22.77M 21.04M 19.35M 36.52M 2.5B 37.1M 252M 98.64M 1.23B 97.53M 95.4M 4.22B 1.92B 37.68M 33.03M 30.53M 28.08M 52.98M 3.63B 53.83M 365M 143M 1.78B 141M 138M 6.13B
Net Debt 5.82B 114M 99.82M 92.27M 84.86M 160M 10.98B 163M 1.1B 432M 5.37B 428M 418M 18.51B 5.77B 113M 99.05M 91.55M 84.2M 159M 10.9B 161M 1.09B 429M 5.33B 424M 415M 18.37B
Logo Ibnsina Pharma
Ibnsina Pharma S.A.E. is Egypt's number two in the wholesale distribution of pharmaceutical products. The group offers medicines and cosmetics to more than 35,000 private and public sector customers (distribution chains, pharmacies, wholesalers and health establishments) through 55 sites located in Egypt.
Employees
5,500
Date Price Change Volume
26-07-20 EGP 11.47 -0.09% 3,122,576
26-07-19 EGP 11.48 -0.17% 5,321,851
26-07-16 EGP 11.50 +1.05% 7,067,204
26-07-15 EGP 11.38 -0.18% 4,143,450
26-07-14 EGP 11.40 -0.61% 4,162,006
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
11.47EGP
Average target price
17.26EGP
Spread / Average Target
+50.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ISPH Stock